Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,244 | -13,546 | -6,401 | -29,152 | -23,647 |
| Depreciation Amortization | 268 | 233 | 100 | 563 | 447 |
| Accounts payable and accrued liabilities | -1,676 | -1,506 | -914 | 9 | -527 |
| Other Working Capital | -4,583 | -4,790 | -1,813 | -1,231 | -449 |
| Other Operating Activity | 1,884 | 1,537 | 831 | 1,636 | 2,332 |
| Operating Cash Flow | $-25,351 | $-18,072 | $-8,197 | $-28,175 | $-21,844 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -115 | -97 | -57 | -159 | -43 |
| Purchase Of Investment | -8,981 | -8,981 | -8,981 | -126,215 | -61,025 |
| Sale Of Investment | 55,679 | 37,679 | 18,000 | 19,001 | 2,001 |
| Investing Cash Flow | $46,583 | $28,601 | $8,962 | $-107,373 | $-59,067 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -9,472 | -9,441 | -1,750 | -5,833 | -4,083 |
| Common Stock Issued | 106 | 103 | 62 | 117,387 | 114,954 |
| Other Financing Activity | 1,510 | -28 | -15 | -247 | -216 |
| Financing Cash Flow | $-7,856 | $-9,366 | $-1,703 | $111,307 | $110,655 |
| Beginning Cash Position | 12,589 | 12,589 | 12,589 | 36,830 | 36,830 |
| End Cash Position | 25,965 | 13,752 | 11,651 | 12,589 | 66,574 |
| Net Cash Flow | $13,376 | $1,163 | $-938 | $-24,241 | $29,744 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,351 | -18,072 | -8,197 | -28,175 | -21,844 |
| Capital Expenditure | -115 | -97 | -57 | -159 | -43 |
| Free Cash Flow | -25,466 | -18,169 | -8,254 | -28,334 | -21,887 |